LA JOLLA PHARMACEUTICAL CO Forms 3, 4 and 5: Other
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 10 rows, 10 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2020-12-15: Reporting owner Hearne Michael S; Form 4; Security Common Stock; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2013-03-22: Reporting owner Reinisch Richard; Form 3; Security La Jolla Pharmaceutical Company; Transaction Holding.
- 2013-03-19: Reporting owner Reinisch Richard; Form 4; Security La Jolla Pharmaceutical Company; Transaction P Open market or private purchase of non-derivative or derivative security.
- 2013-03-19: Reporting owner Reinisch Richard; Form 4; Security La Jolla Pharmaceutical Company; Transaction P Open market or private purchase of non-derivative or derivative security.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2020-12-15 | Hearne Michael S Officer (Chief Financial Officer) | 4 | Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +147 147 owned after | $4.50 exercise price | 2020-12-16 | |
| 2013-03-22 holding as of filing | Reinisch Richard Other (Individual Investor) | 3 | La Jolla Pharmaceutical Company Non-derivative · Direct | Holding | 1,100,000 owned after | no price filed | 2013-03-22 | |
| 2013-03-19 | Reinisch Richard Other (Individual Investor) | 4 | La Jolla Pharmaceutical Company Non-derivative · Direct | P Open market or private purchase of non-derivative or derivative security | +80,000 1,080,000 owned after | $0.09 | 2013-03-22 | |
| 2013-03-19 | Reinisch Richard Other (Individual Investor) | 4 | La Jolla Pharmaceutical Company Non-derivative · Direct | P Open market or private purchase of non-derivative or derivative security | +20,000 1,100,000 owned after | $0.09 | 2013-03-22 | |
| 2012-08-02 | Reinisch Richard Other (Individual Investor) | 4 | La Jolla Pharmaceutical Company Non-derivative · Direct | P Open market or private purchase of non-derivative or derivative security | +220,695 1,000,000 owned after | $0.10 | 2013-03-22 | |
| 2012-08-01 | Reinisch Richard Other (Individual Investor) | 4 | La Jolla Pharmaceutical Company Non-derivative · Direct | P Open market or private purchase of non-derivative or derivative security | +279,305 779,305 owned after | $0.10 | 2013-03-22 | |
| 2012-07-25 | Reinisch Richard Other (Individual Investor) | 4 | La Jolla Pharmaceutical Company Non-derivative · Direct | P Open market or private purchase of non-derivative or derivative security | +121,200 500,000 owned after | $0.09 | 2013-03-22 | |
| 2012-07-24 | Reinisch Richard Other (Individual Investor) | 4 | La Jolla Pharmaceutical Company Non-derivative · Direct | P Open market or private purchase of non-derivative or derivative security | +144,780 378,800 owned after | $0.09 | 2013-03-22 | |
| 2012-07-23 | Reinisch Richard Other (Individual Investor) | 4 | La Jolla Pharmaceutical Company Non-derivative · Direct | P Open market or private purchase of non-derivative or derivative security | +234,000 234,020 owned after | $0.08 | 2013-03-22 | |
| 2010-03-12 | Reinisch Richard Other (Individual Investor) | 4 | La Jolla Pharmaceutical Company Non-derivative · Direct | P Open market or private purchase of non-derivative or derivative security | +20 20 owned after | $936.20 | 2013-03-22 |